LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, today announced continued advancement of its mobile healthcare application ecosystem, including applications being prepared for anticipated future availability through both the Apple App Store and Google Play Store. The applications currently under development are intended to support various telehealth, healthcare communication, patient engagement, provider coordination, emergency response, and AI-assisted healthcare support initiatives as part of the Company's broader digital healthcare infrastructure strategy.
Management stated that the Company is continuing development, testing, integration, and platform optimization efforts relating to multiple mobile healthcare applications intended to support broader healthcare accessibility and digital healthcare coordination initiatives throughout emerging markets, including Latin America. Certain applications are presently being prepared for anticipated future submission and availability through the Apple App Store and Google Play Store following continued development, internal testing, platform review processes, and applicable regulatory considerations.
In connection with these ongoing development efforts, the Company also announced that it has surpassed 1,000 early-stage platform subscribers, which management believes reflects continued early interest and engagement with the LataMed AI healthcare technology ecosystem. The Company believes continued onboarding activity and user engagement may provide valuable operational feedback as development efforts progress and additional platform functionality is evaluated and refined.
LataMed AI also noted that its broader technology initiatives remain focused on scalable healthcare infrastructure solutions intended to support underserved and developing markets where access to healthcare coordination, telehealth services, and digital healthcare tools may be limited or fragmented. Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives."
The Company emphasized that the applications and related platform technologies remain under active development and have not yet been fully commercialized or broadly deployed. No assurance can be provided regarding the timing of any public release, App Store or Google Play availability, regulatory progression, commercialization initiatives, future platform functionality, or operational success of the applications or related technologies. For more information, please visit https://latamed.ai, follow the Company's official Instagram page at https://www.instagram.com/latamedai, or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This announcement is important because it signals LataMed AI's progress in developing a mobile healthcare ecosystem that could improve healthcare accessibility in underserved regions, while the milestone of 1,000 early subscribers indicates growing market validation for its platform.
